{"id":1010,"date":"2026-03-06T17:35:28","date_gmt":"2026-03-06T16:35:28","guid":{"rendered":"https:\/\/animalwelfare.iph-multisite.berta-bewegt.ch\/?page_id=1010"},"modified":"2026-03-09T17:24:37","modified_gmt":"2026-03-09T16:24:37","slug":"4-international-collaboration","status":"publish","type":"page","link":"https:\/\/animalwelfare.interpharma.ch\/en\/topics\/beispiele\/development-of-vaccines-and-tests-for-sars-cov-2\/4-international-collaboration\/","title":{"rendered":"4. International collaboration"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">4. International collaboration<\/h2>\n\n\n\n<p>This rapid development of different vaccines is an extraordinary achievement that was made possible by an unparalleled international collaboration on all levels. Research-based companies had already gathered initial experience of dealing with coronaviruses with SARS-CoV-1 in the early 2000s \u2013 and MERS in 2012. As a consequence, the genetic code of the virus in the Covid-19 pandemic was deciphered early on. On the basis of the information available, various companies were able to begin work on the development of a vaccine. The collaboration between academic institutions and the pharmaceutical industry also served to accelerate vaccine development.<\/p>\n\n\n\n<p>AstraZeneca, for example, developed a vector vaccine together with the University of Oxford. Successful cooperation between companies also had an impact: Pfizer developed an mRNA vaccine in collaboration with the German biotech company BioNTech. Johnson &amp; Johnson developed a DNA vaccine using vectors in collaboration with its subsidiary company Janssen and its vaccines site in Bern. This vaccine, too, involves a new technology, which has already proved successful in vaccination against Ebola. With Lonza as a new production partner, Moderna was able to achieve a tenfold increase in the production capacity for its vaccines. As a result of this cooperation, Lonza in turn its expanding its facilities in Visp (VS).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>4. International collaboration This rapid development of different vaccines is an extraordinary achievement that was made possible by an unparalleled international collaboration on all levels. Research-based companies had already gathered initial experience of dealing with coronaviruses with SARS-CoV-1 in the early 2000s \u2013 and MERS in 2012. As a consequence, the genetic code of the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1040,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"page-templates\/unterthema.php","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-1010","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>4. International collaboration - animalwelfare<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/animalwelfare.interpharma.ch\/themen\/beispiele\/impfstoff-und-testentwicklung-fur-sars-cov-2\/4-internationale-zusammenarbeit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"4. International collaboration\" \/>\n<meta property=\"og:description\" content=\"4. International collaboration This rapid development of different vaccines is an extraordinary achievement that was made possible by an unparalleled international collaboration on all levels. Research-based companies had already gathered initial experience of dealing with coronaviruses with SARS-CoV-1 in the early 2000s \u2013 and MERS in 2012. As a consequence, the genetic code of the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/animalwelfare.interpharma.ch\/themen\/beispiele\/impfstoff-und-testentwicklung-fur-sars-cov-2\/4-internationale-zusammenarbeit\/\" \/>\n<meta property=\"og:site_name\" content=\"animalwelfare\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-09T16:24:37+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/animalwelfare.interpharma.ch\/themen\/beispiele\/impfstoff-und-testentwicklung-fur-sars-cov-2\/4-internationale-zusammenarbeit\/\",\"url\":\"https:\/\/animalwelfare.interpharma.ch\/themen\/beispiele\/impfstoff-und-testentwicklung-fur-sars-cov-2\/4-internationale-zusammenarbeit\/\",\"name\":\"4. International collaboration - animalwelfare\",\"isPartOf\":{\"@id\":\"https:\/\/animalwelfare.interpharma.ch\/#website\"},\"datePublished\":\"2026-03-06T16:35:28+00:00\",\"dateModified\":\"2026-03-09T16:24:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/animalwelfare.interpharma.ch\/themen\/beispiele\/impfstoff-und-testentwicklung-fur-sars-cov-2\/4-internationale-zusammenarbeit\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/animalwelfare.interpharma.ch\/themen\/beispiele\/impfstoff-und-testentwicklung-fur-sars-cov-2\/4-internationale-zusammenarbeit\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/animalwelfare.interpharma.ch\/themen\/beispiele\/impfstoff-und-testentwicklung-fur-sars-cov-2\/4-internationale-zusammenarbeit\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\/\/animalwelfare.interpharma.ch\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Content\",\"item\":\"https:\/\/animalwelfare.interpharma.ch\/en\/topics\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Examples\",\"item\":\"https:\/\/animalwelfare.interpharma.ch\/themen\/beispiele\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Development of vaccines and tests for SARS-CoV-2\",\"item\":\"https:\/\/animalwelfare.interpharma.ch\/themen\/beispiele\/impfstoff-und-testentwicklung-fur-sars-cov-2\/\"},{\"@type\":\"ListItem\",\"position\":5,\"name\":\"4. International collaboration\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/animalwelfare.interpharma.ch\/#website\",\"url\":\"https:\/\/animalwelfare.interpharma.ch\/\",\"name\":\"animalwelfare\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/animalwelfare.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"4. International collaboration - animalwelfare","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/animalwelfare.interpharma.ch\/themen\/beispiele\/impfstoff-und-testentwicklung-fur-sars-cov-2\/4-internationale-zusammenarbeit\/","og_locale":"en_US","og_type":"article","og_title":"4. International collaboration","og_description":"4. International collaboration This rapid development of different vaccines is an extraordinary achievement that was made possible by an unparalleled international collaboration on all levels. Research-based companies had already gathered initial experience of dealing with coronaviruses with SARS-CoV-1 in the early 2000s \u2013 and MERS in 2012. As a consequence, the genetic code of the [&hellip;]","og_url":"https:\/\/animalwelfare.interpharma.ch\/themen\/beispiele\/impfstoff-und-testentwicklung-fur-sars-cov-2\/4-internationale-zusammenarbeit\/","og_site_name":"animalwelfare","article_modified_time":"2026-03-09T16:24:37+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/animalwelfare.interpharma.ch\/themen\/beispiele\/impfstoff-und-testentwicklung-fur-sars-cov-2\/4-internationale-zusammenarbeit\/","url":"https:\/\/animalwelfare.interpharma.ch\/themen\/beispiele\/impfstoff-und-testentwicklung-fur-sars-cov-2\/4-internationale-zusammenarbeit\/","name":"4. International collaboration - animalwelfare","isPartOf":{"@id":"https:\/\/animalwelfare.interpharma.ch\/#website"},"datePublished":"2026-03-06T16:35:28+00:00","dateModified":"2026-03-09T16:24:37+00:00","breadcrumb":{"@id":"https:\/\/animalwelfare.interpharma.ch\/themen\/beispiele\/impfstoff-und-testentwicklung-fur-sars-cov-2\/4-internationale-zusammenarbeit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/animalwelfare.interpharma.ch\/themen\/beispiele\/impfstoff-und-testentwicklung-fur-sars-cov-2\/4-internationale-zusammenarbeit\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/animalwelfare.interpharma.ch\/themen\/beispiele\/impfstoff-und-testentwicklung-fur-sars-cov-2\/4-internationale-zusammenarbeit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/animalwelfare.interpharma.ch\/en\/"},{"@type":"ListItem","position":2,"name":"Content","item":"https:\/\/animalwelfare.interpharma.ch\/en\/topics\/"},{"@type":"ListItem","position":3,"name":"Examples","item":"https:\/\/animalwelfare.interpharma.ch\/themen\/beispiele\/"},{"@type":"ListItem","position":4,"name":"Development of vaccines and tests for SARS-CoV-2","item":"https:\/\/animalwelfare.interpharma.ch\/themen\/beispiele\/impfstoff-und-testentwicklung-fur-sars-cov-2\/"},{"@type":"ListItem","position":5,"name":"4. International collaboration"}]},{"@type":"WebSite","@id":"https:\/\/animalwelfare.interpharma.ch\/#website","url":"https:\/\/animalwelfare.interpharma.ch\/","name":"animalwelfare","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/animalwelfare.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/animalwelfare.interpharma.ch\/en\/wp-json\/wp\/v2\/pages\/1010","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/animalwelfare.interpharma.ch\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/animalwelfare.interpharma.ch\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/animalwelfare.interpharma.ch\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/animalwelfare.interpharma.ch\/en\/wp-json\/wp\/v2\/comments?post=1010"}],"version-history":[{"count":2,"href":"https:\/\/animalwelfare.interpharma.ch\/en\/wp-json\/wp\/v2\/pages\/1010\/revisions"}],"predecessor-version":[{"id":3762,"href":"https:\/\/animalwelfare.interpharma.ch\/en\/wp-json\/wp\/v2\/pages\/1010\/revisions\/3762"}],"up":[{"embeddable":true,"href":"https:\/\/animalwelfare.interpharma.ch\/en\/wp-json\/wp\/v2\/pages\/1040"}],"wp:attachment":[{"href":"https:\/\/animalwelfare.interpharma.ch\/en\/wp-json\/wp\/v2\/media?parent=1010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}